Compared to non-active control treatments , NF appears to have more durable treatment effects , for at least 6 months following treatment .
Neurofeedback ( NF ) has gained increasing interest in the treatment of attention-deficit/hyperactivity disorder ( ADHD ) .
Given learning principles underlie NF , lasting clinical treatment effects may be expected .
This systematic review and meta- analysis addresses the sustainability of neurofeedback and control treatment effects by considering r and omized controlled studies that conducted follow-up ( FU ; 2–12 months ) assessment s among children with ADHD .
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder.
OBJECTIVE In the Multimodal Treatment Study of ADHD ( MTA ) , the effects of medication management ( MedMgt ) and behavior modification therapy ( Beh ) and their combination ( Comb ) and usual community comparison ( CC ) in the treatment of attention-deficit/hyperactivity disorder ( ADHD ) differed at the 14-month assessment as a result of superiority of the MTA MedMgt strategy ( Comb or MedMgt ) over Beh and CC and modest additional benefits of Comb over MedMgt alone . Here we evaluate the persistence of these beneficial effects 10 months beyond the 14 months of intensive intervention . METHODS Of 579 children who entered the study , 540 ( 93 % ) participated in the first follow-up 10 months after the end of treatment . Mixed-effects regression models explored possible persisting effects of the MTA medication strategy , the incremental benefits of Comb over MedMgt alone , and the possible superiority of Beh over CC on 5 effectiveness and 4 service use domains . RESULTS The MTA medication strategy showed persisting significant superiority over Beh and CC for ADHD and oppositional-defiant symptoms at 24 months , although not as great as at 14 months . Significant additional benefits of Comb over MedMgt and of Beh over CC were not found . The groups differed significantly in mean dose ( methylpheni date equivalents 30.4 , 37.5 , 25.7 , and 24.0 mg/day , respectively ) . Continuing medication use partly mediated the persisting superiority of Comb and MedMgt . CONCLUSION The benefits of intensive MedMgt for ADHD extend 10 months beyond the intensive treatment phase only in symptom domains and diminish over time
Compared to non-active control treatments , NF appears to have more durable treatment effects , for at least 6 months following treatment .
Neurofeedback ( NF ) has gained increasing interest in the treatment of attention-deficit/hyperactivity disorder ( ADHD ) .
Given learning principles underlie NF , lasting clinical treatment effects may be expected .
This systematic review and meta- analysis addresses the sustainability of neurofeedback and control treatment effects by considering r and omized controlled studies that conducted follow-up ( FU ; 2–12 months ) assessment s among children with ADHD .